Белки острой фазы воспаления и адипоцитокины в сыворотке крови у женщин с сахарным диабетом 2-го типа: взаимосвязи с составом тела и колебаниями уровня глюкозы в крови
- Авторы: Климонтов ВВ1, Тян НВ1, Фазуллина ОН1, Мякина НЕ1, Орлов НБ1, Коненков ВИ1
-
Учреждения:
- Научно-исследовательский институт клинической и экспериментальной лимфологии
- Выпуск: Том 88, № 10 (2016)
- Страницы: 35-41
- Раздел: Передовая статья
- Статья получена: 11.04.2020
- Статья опубликована: 15.10.2016
- URL: https://ter-arkhiv.ru/0040-3660/article/view/32642
- DOI: https://doi.org/10.17116/terarkh2016881035-41
- ID: 32642
Цитировать
Полный текст
Аннотация
Ключевые слова
Об авторах
В В Климонтов
Научно-исследовательский институт клинической и экспериментальной лимфологииНовосибирск, Россия
Н В Тян
Научно-исследовательский институт клинической и экспериментальной лимфологииНовосибирск, Россия
О Н Фазуллина
Научно-исследовательский институт клинической и экспериментальной лимфологииНовосибирск, Россия
Н Е Мякина
Научно-исследовательский институт клинической и экспериментальной лимфологииНовосибирск, Россия
Н Б Орлов
Научно-исследовательский институт клинической и экспериментальной лимфологииНовосибирск, Россия
В И Коненков
Научно-исследовательский институт клинической и экспериментальной лимфологииНовосибирск, Россия
Список литературы
- Hameed I, Masoodi SR, Mir SA, Nabi M, Ghazanfar K, Ganai BA. Type 2 diabetes mellitus: From a metabolic disorder to an inflammatory condition. World J Diabetes. 2015;6(4):598-612. doi: 10.4239/wjd.v6.i4.598
- Flehmig G, Scholz M, Klöting N, Fasshauer M, Tönjes A, Stumvoll M, Youn BS, Blüher M. Identification of adipokine clusters related to parameters of fat mass, insulin sensitivity and inflammation. PLoS One. 2014;9(6):e99785. doi: 10.1371/journal.pone.0099785
- Andrade-Oliveira V, Câmara NO, Moraes-Vieira PM. Adipokines as drug targets in diabetes and underlying disturbances. JDiabetes Res. 2015;681612. doi: 10.1155/2015/681612
- Коненков В.И., Климонтов В.В., Мякина Н.Е., Тян Н.В., Фазуллина О.Н., Романов В.В. Повышенная концентрация воспалительных цитокинов в сыворотке крови у больных сахарным диабетом 2-го типа с хронической болезнью почек. Терапевтический архив. 2015;6:45-49.
- Cao H. Adipocytokines in obesity and metabolic disease. Endocrinol. 2014;220(2):T47-59. doi: 10.1530/JOE-13-0339
- Haase J, Weyer U, Immig K, Klöting N, Blüher M, Eilers J, Bechmann I, Gericke M. Local proliferation of macrophages in adipose tissue during obesity-induced inflammation. Diabetologia. 2014;57(3):562-571. doi: 10.1007/s00125-013-3139-y
- Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract. 2014;105(2):141-150. doi: 10.1016/j.diabres.2014.04.006
- Wronkowitz N, Romacho T, Sell H, Eckel J. Adipose tissue dysfunction and inflammation in cardiovascular disease. Front Horm Res.2014;43:79-92. doi: 10.1159/000360560
- Hill NR, Nick SO, Choudhary P, Levy JC, Hindmarsh P, Matthews DR. Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups. Diabetes Technol Ther. 2011;13(9):921-928. doi: 10.1089/dia.2010.0247
- Service FJ. Glucose variability. Diabetes. 2013; 62(5):1398-1404. doi: 10.2337/db12-1396
- Климонтов В.В., Мякина Н.Е. Вариабельность гликемии при сахарном диабете: инструмент для оценки качества гликемического контроля и риска осложнений. Сахарный диабет. 2014;2:18-24. doi: 10.14341/DM20142
- Swift DL, Johannsen NM, Earnest CP, Blair SN, Church TS. Effect of exercise training modality on C-reactive protein in type 2 diabetes. Med Sci Sports Exerc. 2012;44(6):1028-1034. doi: 10.1249/MSS.0b013e31824526cc
- Saito T, Murata M, Otani T, Tamemoto H, Kawakami M, Ishikawa SE. Association of subcutaneous and visceral fat mass with serum concentrations of adipokines in subjects with type 2 diabetes mellitus. Endocr J. 2012;59(1):39-45.
- Litvinova L, Atochin D, Vasilenko M, Fattakhov N, Zatolokin P, Vaysbeyn I, Kirienkova E. Role of adiponectin and proinflammatory gene expression in adipose tissue chronic inflammation in women with metabolic syndrome. Diabetol Metab Syndr. 2014;6(1):137. doi: 10.1186/1758-5996-6-137
- Bruun JM, Lihn AS, Madan AK, Pedersen SB, Schiøtt KM, Fain JN, Richelsen B. Higher production of IL-8 in visceral vs. subcutaneous adipose tissue. Implication of nonadipose cells in adipose tissue. Am J Physiol Endocrinol Metab. 2004;286(1):E8-E13.
- Samaras K, Botelho NK, Chisholm DJ, Lord RV. Subcutaneous and visceral adipose tissue gene expression of serum adipokines that predict type 2 diabetes. Obesity (Silver Spring). 2010;18(5):884-889. doi: 10.1038/oby.2009.443
- van Beek L, Lips MA, Visser A, Pijl H, Ioan-Facsinay A, Toes R, Berends FJ, Willems van Dijk K, Koning F, van Harmelen V. Increased systemic and adipose tissue inflammation differentiates obese women with T2DM from obese women with normal glucose tolerance. Metabolism. 2014;63(4):492-501. doi: 10.1016/j.metabol.2013.12.002
- Poland DC, Schalkwijk CG, Stehouwer CD, Koeleman CA, van het Hof B, van Dijk W. Increased alpha3-fucosylation of alpha1-acid glycoprotein in Type I diabetic patients is related to vascular function. Glycoconj J. 2001;18(3):261-268.
- Fournier T, Medjoubi-N N, Porquet D. Alpha-1-acid glycoprotein. Biochim Biophys Acta. 2000;1482(1-2):157-171. doi: 10.1016/S0167-4838(00)00153-9
- Alfadda AA, Fatma S, Chishti MA, Al-Naami MY, Elawad R, Mendoza CD, Jo H, Lee YS. Orosomucoid serum concentrations and fat depot-specific mRNA and protein expression in humans. Mol Cells. 2012;33(1):35-41. doi: 10.1007/s10059-012-2181-9.
- Lee YS., Choi JW, Hwang I, Lee JW, Lee JH, Kim AY, Huh JY, Koh YJ, Koh GY, Son HJ, Masuzaki H, Hotta K, Alfadda AA, Kim JB. Adipocytokine orosomucoid integrates inflammatory and metabolic signals to preserve energy homeostasis by resolving immoderate inflammation. J Biol Chem. 2010;285(29):22174-22185. doi: 10.1074/jbc.M109.085464
- Würtz P, Tiainen M, Mäkinen VP, Kangas AJ, Soininen P, Saltevo J, Keinänen-Kiukaanniemi S, Mäntyselkä P, Lehtimäki T, Laakso M, Jula A, Kähönen M, Vanhala M, Ala-Korpela M. Circulating metabolite predictors of glycemia in middle-aged men and women. Diabetes Care. 2012;35(8):1749-1756. doi: 10.2337/dc11-1838
- Brasacchio D, Okabe J, Tikellis C, Balcerczyk A, George P, Baker EK, Calkin AC, Brownlee M, Cooper ME, El-Osta A. Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail. Diabetes. 2009;58(5):1229-1236. doi: 10.2337/db08-1666
- Piconi L, Quagliaro L, Da Ros R, Assaloni R, Giugliano D, Esposito K, Szabó C, Ceriello A. Intermittent high glucose enhances ICAM-1, VCAM-1, E-selectin and interleukin-6 expression in human umbilical endothelial cells in culture: the role of poly(ADP-ribose) polymerase. J Thromb Haemost. 2004;2(8):1453-1459.
- КоненковВ.И., ШевченкоА.В., ПрокофьевВ.Ф., КлимонтовВ.В., КоролевМ.А., ФазуллинаО.Н., ЛапсинаС.А., КоролеваЕ.А. Ассоциациявариантовгенафактораростасосудистогоэндотелия (VEGF) игеновцитокинов (IL-1B, IL4, IL8, IL10, TNFA) ссахарнымдиабетом 2 типауженщин. Сахарный диабет. 2012;3:4-10. doi: 10.14341/2072-0351-6079
- Al-Daghri NM, Al-Attas OS, Krishnaswamy S, Mohammed AK, Alenad AM, Chrousos GP, Alokail MS. Association of Type 2 Diabetes Mellitus related SNP genotypes with altered serum adipokine levels and metabolic syndrome phenotypes. Int J Clin Exp Med. 2015;8(3):4464-4471.
- Daniele G, Guardado Mendoza R, Winnier D, Fiorentino TV, Pengou Z, Cornell J, Andreozzi F, Jenkinson C, Cersosimo E, Federici M, Tripathy D, Folli F. The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus. Acta Diabetol. 2014;51(1):123-131. doi: 10.1007/s00592-013-0543-1
- Tabák AG, Kivimäki M, Brunner EJ, Lowe GD, Jokela M, Akbaraly TN, Singh-Manoux A, Ferrie JE, Witte DR. Changes in C-reactive protein levels before type 2 diabetes and cardiovascular death: the Whitehall II study. Eur J Endocrinol. 2010;163(1):89-95. doi: 10.1530/EJE-10-0277
- Belalcazar LM, Reboussin DM, Haffner SM, Hoogeveen RC, Kriska AM, Schwenke DC, Tracy RP, Pi-Sunyer FX, Ballantyne CM. Look AHEAD Research Group. A 1-year lifestyle intervention for weight loss in individuals with type 2 diabetes reduces high C-reactive protein levels and identifies metabolic predictors of change: from the Look AHEAD (Action for Health in Diabetes) study. Diabetes Care. 2010;33(11):2297-2303. doi: 10.2337/dc10-0728
- Mavros Y, Kay S, Simpson KA, Baker MK, Wang Y, Zhao RR, Meiklejohn J, Climstein M, O’Sullivan AJ, de Vos N, Baune BT, Blair SN, Simar D, Rooney K, Singh NA, Fiatarone Singh MA. Reductions in C-reactive protein in older adults with type 2 diabetes are related to improvements in body composition following a randomized controlled trial of resistance training. J Cachexia Sarcopenia Muscle. 2014;5(2):111-120. doi: 10.1007/s13539-014-0134-1
- Vepsäläinen T, Soinio M, Marniemi J, Lehto S, Juutilainen A, Laakso M, Rönnemaa T. Physical activity, high-sensitivity C-reactive protein, and total and cardiovascular disease mortality in type 2 diabetes. Diabetes Care. 2011;34(7):1492-1496. doi: 10.2337/dc11-0469
- Shirakawa J, Fujii H, Ohnuma K, Sato K, Ito Y, Kaji M, Sakamoto E, Koganei M, Sasaki H, Nagashima Y, Amo K, Aoki K, Morimoto C, Takeda E, Terauchi Y. Diet-induced adipose tissue inflammation and liver steatosis are prevented by DPP-4 inhibition in diabetic mice. Diabetes. 2011;60(4):1246-1257. doi: 10.2337/db10-1338
- Satoh-Asahara N, Sasaki Y, Wada H, Tochiya M, Iguchi A, Nakagawachi R, Odori S, Kono S, Hasegawa K, Shimatsu A. A dipeptidyl peptidase-4 inhibitor, sitagliptin, exerts anti-inflammatory effects in type 2 diabetic patients. Metabolism. 2013;62(3):347-351. doi: 10.1016/j.metabol.2012.09.004
- Rizzo MR, Barbieri M, Marfella R, Paolisso G. Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-IV inhibition. Diabetes Care. 2012;35(10):2076-2082.
- Andrade-Oliveira V, Câmara NO, Moraes-Vieira PM. Adipokines as drug targets in diabetes and underlying disturbances.J Diabetes Res. 2015;2015:681612. doi: 10.1155/2015/681612
Дополнительные файлы
![](/img/style/loading.gif)